|
Q |
Bp197 |
Blood pressure QTL 197 |
|
IEA |
|
RGD |
PMID:8528250 |
RGD:61060 |
NCBI chr 1:158,633,083...203,633,083
|
|
Q |
Bp283 |
Blood pressure QTL 283 |
|
IEA |
|
RGD |
PMID:11053483 |
RGD:70856 |
|
|
Q |
BpQTLcluster14 |
Blood pressure QTL cluster 14 |
|
IEA |
|
RGD |
PMID:10779487 |
RGD:68932 |
NCBI chr17:1...31,990,913
|
|
Q |
Cia10 |
Collagen induced arthritis QTL 10 |
|
IEA |
|
RGD |
PMID:9870869 |
RGD:61063 |
NCBI chr 2:179,946,951...224,946,951
|
|
Q |
Cia9 |
Collagen induced arthritis QTL 9 |
|
IEA |
|
RGD |
PMID:9870869 |
RGD:61063 |
|
|
Q |
Eae12 |
Experimental allergic encephalomyelitis QTL 12 |
|
IEA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr10:92,238,497...101,012,337
|
|
Q |
Eae13 |
Experimental allergic encephalomyelitis QTL 13 |
|
IEA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr12:24,139,202...36,638,073
|
|
Q |
Eae14 |
Experimental allergic encephalomyelitis QTL 14 |
|
IEA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr13:23,203,448...68,203,448
|
|
Q |
Eae15 |
Experimental allergic encephalomyelitis QTL 15 |
|
IEA |
|
RGD |
PMID:10545597 |
RGD:69695 |
NCBI chr18:76,477,814...77,209,844
|
|
Q |
Gcr1 |
Gastric cancer resistance QTL 1 |
|
IEA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 4:120,260,281...147,278,687
|
|
Q |
Gcr2 |
Gastric cancer resistance QTL 2 |
|
IEA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 3:8,658,162...27,494,778
|
|
Q |
Gcr3 |
Gastric cancer resistance QTL 3 |
|
IEA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr16:17,696,791...82,635,055
|
|
Q |
Gcs1 |
Gastric cancer susceptibility QTL1 |
|
IEA |
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr15:76,306,099...101,769,107
|
|
Q |
Rf1 |
Renal disease susceptibility QTL 1 |
|
IEA |
|
RGD |
PMID:8528250 |
RGD:61060 |
|
|
Q |
Rf2 |
Renal disease susceptibility QTL 2 |
|
IEA |
|
RGD |
PMID:8528250 |
RGD:61060 |
NCBI chr 1:99,267,916...144,267,916
|
|
Q |
Rf3 |
Renal disease susceptibility QTL 3 |
|
IEA |
|
RGD |
PMID:11053483 |
RGD:70856 |
NCBI chr 3:107,693,393...152,693,393
|
|
Q |
Rf4 |
Renal disease susceptibility QTL 4 |
|
IEA |
|
RGD |
PMID:11053483 |
RGD:70856 |
NCBI chr14:1...32,754,612
|
|
Q |
Rf5 |
Renal disease susceptibility QTL 5 |
|
IEA |
|
RGD |
PMID:11053483 |
RGD:70856 |
|
|
Q |
Swd1 |
Spike wave discharge measurement QTL 1 |
|
IEA |
|
RGD |
PMID:15270755 |
RGD:1302436 |
NCBI chr 9:101,597,509...102,302,863
|
|
Q |
Swd2 |
Spike wave discharge measurement QTL 2 |
|
IEA |
|
RGD |
PMID:15270755 |
RGD:1302436 |
NCBI chr 5:151,113,452...164,465,185
|
|
|
Q |
Leukc1 |
Leukocyte quantity QTL 1 |
|
IEA |
|
RGD |
PMID:16151696 |
RGD:5135221 |
NCBI chr19:44,340,214...55,283,277
|
|
Q |
Leukc2 |
Leukocyte quantity QTL 2 |
|
IEA |
|
RGD |
PMID:16151696 |
RGD:5135221 |
NCBI chr 2:118,111,229...149,559,726
|
|
Q |
Leukc3 |
Leukocyte quantity QTL 3 |
|
IEA |
|
RGD |
PMID:17090969 |
RGD:5135222 |
NCBI chr 1:218,108,584...224,054,420
|
|
|
Q |
Cia25 |
Collagen induced arthritis QTL 25 |
|
IEA |
|
RGD |
PMID:15334486 |
RGD:1285224 |
NCBI chr12:19,610,889...35,682,913
|
|
Q |
Cia26 |
Collagen induced arthritis QTL 26 |
|
IEA |
|
RGD |
PMID:15334486 |
RGD:1285224 |
NCBI chr18:54,709,769...83,828,827
|
|
Q |
Colcr1 |
Colorectal carcinoma resistance QTL 1 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 4:1...29,494,328
|
|
Q |
Colcr2 |
Colorectal carcinoma resistance QTL 2 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:2,266,368...22,711,984
|
|
Q |
Colcr3 |
Colorectal carcinoma resistance QTL 3 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:2,249,477...22,066,430
|
|
Q |
Colcr4 |
Colorectal carcinoma resistance QTL4 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:20,338,777...62,613,667
|
|
Q |
Colcr5 |
Colorectal carcinoma resistance QTL 5 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:122,549,046...137,801,795
|
|
Q |
Colcr6 |
Colorectal carcinoma resistance QTL 6 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:73,690,518...99,794,247
|
|
Q |
Colcr7 |
Colorectal carcinoma resistance QTL 7 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr17:2,115,149...21,881,669
|
|
Q |
Colcr8 |
Colorectal carcinoma resistance QTL 8 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:22,066,242...52,293,055
|
|
Q |
Colcr9 |
Colorectal carcinoma resistance QTL 9 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr20:1,530,655...46,530,655
|
|
Q |
Colcs1 |
Colorectal carcinoma susceptibility QTL 1 |
|
IEA |
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 5:121,846,814...166,846,814
|
|
Q |
Emca1 |
Estrogen-induced mammary cancer QTL 1 |
|
IEA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:99,216,724...148,607,142
|
|
Q |
Emca2 |
Estrogen-induced mammary cancer QTL 2 |
|
IEA |
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:18,007,599...63,571,040
|
|
Q |
Emca4 |
Estrogen-induced mammary cancer QTL 4 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:62,004,452...101,773,158
|
|
Q |
Emca5 |
Estrogen-induced mammary cancer QTL 5 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:43,827,364...169,034,231
|
|
Q |
Emca6 |
Estrogen-induced mammary cancer QTL 6 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:44,463,720...155,883,716
|
|
Q |
Emca7 |
Estrogen-induced mammary cancer QTL 7 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:15,107,216...107,351,382
|
|
Q |
Emca8 |
Estrogen-induced mammary cancer QTL 8 |
|
IEA |
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:50,328,551...141,643,988
|
|
Q |
Ept1 |
Estrogen-induced pituitary tumorigenesis QTL 1 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 6:9,843,312...20,338,915
|
|
Q |
Ept10 |
Estrogen-induced pituitary tumorigenesis QTL 10 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 1:192,825,253...243,914,732
|
|
Q |
Ept13 |
Estrogen-induced pituitary tumorigenesis QTL 13 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 1:77,494,165...122,494,165
|
|
Q |
Ept2 |
Estrogen-induced pituitary tumorigenesis QTL 2 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:47,233,430...110,362,260
|
|
Q |
Ept5 |
Estrogen-induced pituitary tumorigenesis QTL 5 |
|
IEA |
|
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 4:83,428,419...177,635,233
|
|
Q |
Ept6 |
Estrogen-induced pituitary tumorigenesis QTL 6 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr 3:6,537,645...10,778,823
|
|
Q |
Ept7 |
Estrogen-induced pituitary tumorigenesis QTL 7 |
|
IEA |
|
RGD |
PMID:17876666 |
RGD:1642526 |
NCBI chr 7:62,004,452...101,773,158
|
|
Q |
Ept9 |
Estrogen-induced pituitary tumorigenesis QTL 9 |
|
IEA |
|
RGD |
PMID:15687265 |
RGD:1334449 |
NCBI chr10:73,453,136...96,120,911
|
|
Q |
Esta1 |
Estrogen-induced thymic atrophy QTL 1 |
|
IEA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr10:21,329,805...61,345,413
|
|
Q |
Esta2 |
Estrogen-induced thymic atrophy QTL 2 |
|
IEA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr 2:189,599,258...226,936,289
|
|
Q |
Esta3 |
Estrogen-induced thymic atrophy QTL 3 |
|
IEA |
|
RGD |
PMID:16688534 |
RGD:1579780 |
NCBI chr 2:136,916,935...189,599,348
|
|
Q |
Eutr1 |
Estrogen induced uterine response QTL 1 |
|
IEA |
|
RGD |
PMID:16284801 |
RGD:1559292 |
NCBI chr 5:2,138,965...166,875,058
|
|
Q |
Prcr1 |
Prostate cancer resistance QTL 1 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 2:72,532,993...157,142,209
|
|
Q |
Prcr2 |
Prostate cancer resistance QTL 2 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr 1:20,763,158...44,095,856
|
|
Q |
Prcs1 |
Prostate cancer susceptibility QTL 1 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr19:15,114,598...34,521,833
|
|
Q |
Prcs2 |
Prostate cancer susceptibility QTL 2 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr20:4,606,607...17,617,956
|
|
Q |
Renag1 |
Renal agenesis QTL 1 |
|
IEA |
|
RGD |
PMID:16845468 |
RGD:1580355 |
NCBI chr14:8,170,668...68,298,175
|
|
Q |
Tescar1 |
Testicular tumor resistance QTL 1 |
|
IEA |
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr11:1,041,931...66,113,562
|
|